Year: 2017
Drug: Keytruda (Pembrolizumab) to Treat NSCLC
Keytruda (Pembrolizumab) is used to treat non-small cell lung cancer (NSCLC). This cancer medicine interferes with the growth and spread of cancer cells in the [...]
7 Warning Signs of Lung Cancer among Women
Lung cancer is one of the most deadly types of cancer in both men and women. But, as far as the symptoms are concerned, they differ in both genders. Here, we [...]
Drug: Iressa (Gefitinib) to Treat NSCLC
Gefitinib is an FDA-approved drug for the treatment of non-small cell lung cancer. It is also known by its brand name Iressa. It is used for lung cancer [...]
How is Lung Cancer Treated?
There are main two types of lung cancer: small cell lung cancer and non-small cell lung cancer. Lung cancer treatment depends on the stage of lung cancer, [...]
Tagrisso Gets FDA Approval as Lung Cancer Drug
Lung cancer is one of the most deadly diseases among both men and women. A new drug has got FDA approval. AstraZeneca has got its approval for lung cancer drug [...]
High-Glycemic Foods Can Raise the Risk of Lung Cancer
According to a new study published in the journal Cancer Epidemiology, Biomarkers and Prevention, consuming high glycemic index may have a greater risk for [...]
CT Screening Method Allows Early Detection of Lung Cancer
Lung cancer is one of the deadliest cancers in the world. It kills more people each year than combined colon, breast, prostate and pancreatic cancer. One of [...]
Statins Do Not Improve Survival in Small Cell Lung Cancer
Statins are the cholesterol-lowering drugs. Do such drugs could be a part of cancer treatment as well? Such drugs works to lower cholesterol levels by blocking [...]
Study Suggests Antioxidants May Protect From Lung Cancer
Lung cancer is one of the leading causes of death among the people. Cigarette smoking is the major risk factor for the cause of lung cancer. Though it may [...]
Drug: Tarceva (Erlotinib Hydrochloride) to Treat NSCLC
Tarceva (Erlotinib Hydrochloride) is a non-chemotherapy drug for the treatment of lung cancer. It is used in the treatment of recurrent NSCLC. It is approved [...]
Drug: Cyramza (Ramucirumab) to Treat NSCLC
Lung Cancer Treatment
Cyramza (Ramucirumab) is an approved drug for the treatment of non-small cell lung cancer (NSCLC). It was approved by US FDA as a single [...]
Drug: Crizotinib for Lung Cancer
Crizotinib FDA Approved
Among cancer-related deaths in the United States, lung cancer is the leading cause. FDA has approved the use of Xalkori (crizotinib) [...]